References
- Nyrén O, Adami H O, Bates S. Selfrating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol 1987; 9: 408–14
- Svedlund J, Sjodin I, Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129–34
- Jorde R, Burhol P G. Asymptomatic peptic ulcer disease. Review. Scand J Gastroenterol 1987; 22: 129–34
- Klauser A G, Schindlbeck N E, Müller-Lissner S A. Clinical practice. Symptoms in gastrooesophageal reflux disease. Lancet 1990; 335: 205–8
- Texter E C. Ulcer pain mechanisms. The clinical features of active peptic ulcer disease and implications for therapy. Scand J Gastroenterol 1987; 22(Suppl 134)1–20
- Jönsson K A, Gotthard R, Bodemar G. The clinical relevance of endoscopic and histologic inflammation of gas-troduodenal mucosa in dyspepsia of unknown origin. Scand J Gastroenterol 1989; 24: 385–95
- Johannessen T, Petersen H, Kleveland P M. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689–97
- Wiklund I, Dimenas E, Wahl M. Factors of importance when evaluating Quality of Life in clinical trials. Controlled Clinical Trials 1990; 11: 169–79
- Stewart A L, Greenfield S, Hays R D. Functional status and well-being of patients with chronic conditions. JAMA 1989; 262: 907–13
- Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia, comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495–8
- Kettell J, Jones R, Lydeard S. Reasons for consultation in irritable bowel syndrome, symptoms and patient characteristics. Br J Gen Pract 1992; 42: 459–61
- Kumar D, Pfeffer J, Wingate D L. Role of psychological factors in the irritable bowel syndrome. Digestion 1990; 45: 80–7
- Walker E A, Roy-Byrne P P, Katon W J. Psychiatric illness and irritable bowel syndrome. A comparison with inflammatory bowel disease. Am J Psychiatry 1990; 147: 1656–61
- Creed F, Guthire E. Psychological factors in the irritable bowel syndrome. Progress report. Gut 1987; 28: 1307–18
- Whitehead W, Bosmajian L, Zonderman A B. Symptoms of psychological distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988; 95: 709–14
- Drossman D A, McKee D C, Sandler R S. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701–8
- Smith R C, Greenbaum D S, Vancouver J B. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 1990; 98: 293–301
- Whitehead W E, Winget C, Fedoravicius A S. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982; 27: 202–8
- Nyrén O, Adami H O, Gustavsson S. Excess sick-listing in nonulcer dyspepsia. J Clin Gastroenterol 1986; 8: 339–45
- Whitehead W E, Crowell M D, Robinson J C. Effects of stressful life events on bowel symptoms, subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825–30
- Johnsen R, Jacobsen Koster B, Fflrde O H. Associations between symptoms of irritable colon and psychological and social conditions and lifestyle. Br Med J 1986; 292: 1633–5
- Page M C, Lacey L A, Mills J G. Can higher doses of an H2 receptor antagonist accelerate duodenal ulcer healing?. Aliment Pharmacol Therap 1989; 3: 425–33
- Mills J G, Lee F I, Johnson N J. Effects of higher dose ranitidine therapy on duodenal ulcer healing. Eur J Gastroenterol Hepatol 1991; 3: 435–41
- Johnson N J, Boyd E JS, Mills J G. Acute treatment of reflux oesophagitis. A multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Therap 1989; 3: 259–66
- Johnson N J, Laws S, Mills J G. Effect of three ranitidine dosage regiments in the treatment of reflux oesophagitis. Result of a multicentre trial. Eur J Gastroenterol Hepatol 1991; 3: 769–74
- Berlin R G. Effects of H2 receptor antagonists on the central nervous system. Drug Dev Res 1989; 17: 97–108